aTyr Pharma reported $-121.47K in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
Alterity Therapeutics Limited AUD -8.07M 302.4K Dec/2025
Ardelyx USD -30.68M 35.78M Mar/2026
aTyr Pharma USD -121.47K 24.59M Mar/2026
Biogen USD 514.3M 502.8M Mar/2026
Bristol-Myers Squibb USD 3.56B 90M Mar/2026
Cipla INR 6.14B 3.63B Mar/2026
Clal Biotechnology ILS -5.44M 3.76M Dec/2022
Compugen USD -9.02M 65.06M Mar/2026
CSL USD 2.64B 116M Dec/2025
Curis USD -7.88M 4.31M Dec/2025
GlaxoSmithKline GBP 2.29B 856M Mar/2026
Grifols EUR 320.55M 91.01M Dec/2025
Lakefront Biotherapeutics EUR -63.7M 844.26M Mar/2026
Novartis USD 4.18B 118M Mar/2026
Roche Holding CHF 9.56B 2.1B Dec/2025
United Therapeutics USD 325.8M 340.4M Mar/2026
Xoma USD -10.08M 4.4M Jun/2024